Sorafenib Tosylate Powder

Sorafenib tosylate Powder is a small molecule lab compound used for oncology pharmacology research. It inhibits multiple tyrosine kinases to block tumor angiogenesis & proliferation, widely deployed to build tumor cell models for antitumor raw material screening and biomedical formula trials.

This research raw material delivers stable tumor suppression inhibition performance. It simulates pathogenic tumor invasion reactions for antitumor ingredient efficacy testing, offering more complete experimental data than single-spectrum reagents.
Ideal for lab pharmacology research and antitumor preservative-related formula development.

◆ Tyrosine Kinase Synthesis Blocking
Reagent for constructing tumor cell models, suppresses tumor proliferation in lab tests.

◆ Broad-spectrum Antitumor Auxiliary Performance
Supports drug sensitivity testing for multiple tumor strains in cellular experiment research.

◆ Anti-tumor Infection Formula Auxiliary
Raw material for antitumor and anti-angiogenesis formula trial development.

◆ Good Formula Compatibility
Uniform mixing with lab culture medium and cosmetic/pharmaceutical base materials.

◆ Biomedical Lab Research
Pharmacology research reagent for tumor‑related cell experiments, applied to explore tumor proliferation, angiogenesis and intracellular kinase signal inhibition mechanisms for oncology basic research.

◆ Pharmaceutical R&D
High‑activity API raw material for anti‑tumor pre‑clinical formulation trials of multi‑kinase inhibitor preparations, supporting dosage‑form screening, compatibility test and early‑stage pharmaceutical development work.

◆ Lab Chemical Customization
High‑purity reference standard for compound synthesis, impurity profiling, quality verification and antitumor potency testing research in lab projects.